Login / Signup

CIDP prognosis in patients with IVIG treatment-related fluctuations.

Melissa CookMamatha PasnoorSenda Ajroud-DrissThomas H BrannaganMazen M DimachkieJeffrey A Allen
Published in: Muscle & nerve (2022)
TRFs are important to identify in order to optimize treatment in real time, but poorly predict long-term disease activity status. The presence of minor TRFs are unlikely to result in substantial accumulation of disability over time. Periodic IVIG optimization trials using objective outcomes are encouraged in all CIDP patients receiving chronic IVIG treatment as a means to identify the lowest effective IVIG dose and frequency.
Keyphrases
  • disease activity
  • rheumatoid arthritis
  • systemic lupus erythematosus
  • multiple sclerosis
  • type diabetes
  • ankylosing spondylitis
  • combination therapy
  • juvenile idiopathic arthritis